Canagliflozin Audit DUK Liverpool, 2019 - Poster

Two year metabolic outcomes in the Association of British Clinical Diabetologist (ABCD) Nationwide Canagliflozin Audit: a comparison of glycaemic improvements

A Puttanna1, M Yadagiri1, P Sen Gupta1, I W Gallen2, A Bickerton3, S Phillips4, A Evans4 , D Sennik5, R E J Ryder1 and ABCD nationwide canagliflozin audit contributors6

1 Sandwell and West Birmingham NHS Trust, Birmingham, UK
2 Royal Berkshire Hospitals NHS Trust, Berkshire, UK
3 RYeovil District Hospital NHS Trust, Yeovil, UK
4 RCheltenham General Hospital, Cheltenham, UK
5 RPrincess Alexandra Hospital, Harlow, UK
6 ABCD nationwide canagliflozin audit contributors, UK

Discipline

Diabetes
Resource taxonomy
Audit Posters
Clinical taxonomy
Treatments for diabetes Type 2 diabetes mellitus
Listing status
Current

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • A. Menarini Diagnostics
  • Advanced Therapeutics (UK) Ltd
  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Bronze

  • Roche Diabetes Care

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd